Cardiomyopathy in congenital disorders of glycosylation

Cardiology in the Young

Volumn 13, Issue 4, 2003, Pages 345-351

  Gehrmann, Josef ^a   Sohlbach, Kristina ^a   Linnebank, Michael ^a   Böhles, Hans Josef ^b   Buderus, Stephan ^c   Gerd Kehl, Hans ^a   Vogt, Johannes ^a   Harms, Erik ^a   Marquardt, Thorsten ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

Dilated cardiomyopathy; Hypertrophic cardiomyopathy; Sudden cardiac death

Indexed keywords

BIOCHEMICAL MARKER; PHOSPHOMANNOMUTASE;

ADOLESCENT; ARTICLE; CARDIOMYOPATHY; CHILD; CHILDHOOD MORTALITY; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COHORT ANALYSIS; CONGENITAL DISORDER OF GLYCOSYLATION; CONGESTIVE CARDIOMYOPATHY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INFANT; MALE; META ANALYSIS; MORBIDITY; STATISTICAL SIGNIFICANCE; SUDDEN DEATH; SYSTEMATIC REVIEW; DISORDERS OF CARBOHYDRATE METABOLISM; GLYCOSYLATION; NEWBORN; REVIEW;

CARBOHYDRATE METABOLISM, INBORN ERRORS; CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLYCOSYLATION; HUMANS; INFANT; INFANT, NEWBORN; MALE;

EID: 2142657353     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S1047951103000702     Document Type: Article

References (25)

1. Marquardt T, Freeze HH. Congenital disorders of glycosylation. Glycosylation defects in man and biological models for their study. Biol Chem 2001; 382: 161-177.
2. Marquardt T, Hülskamp G, Gehrmann J, Debus V, Harms E, Kehl HG. Severe transient myocardial ischaemia causes by hypertrophic cardiomyopathy in a patient with congenital disorder of glycosylation type Ia. Eur J Pediatr 2002; 161: 524-527.
3. Jaeken J, van Eijk HG, van der Heul C, Corbeel L, Eeckels R, Eggermont E. Sialic acid-deficient serum and cerebrospinal fluid transferrin in an newly recognized genetic syndrome. Clin Chim Acta 1984; 144: 245-247.
4. Jaeken J, Vanderschueren-Lodeweyckx M, Casaer P, et al. Familial psychomotor retardation with markedly fluctuating serum prolactin, FSH and GH levels, partial TBG deficiency, increased serum arylsulphatase A and increased CSF protein: A new syndrome? Pediatr Res 1980; 14: 179.
5. Clayton PT, Winchester BG, Keir G. Hypertrophic obstructive cardiomyopathy in a neonate with the carbohydrate-deficient glycoprotein syndrome. J Inher Metab Dis 1992; 15: 857-861.
6. Hagberg BA, Blennow G, Kristiansson B, Stibler H. Carbohydrate-deficient glycoprotein syndromes: Peculiar group of new disorders. Pediatr Neurol 1993; 9: 255-262.
7. Harding BN, Dunger DB, Grant DB, Erdohazi M. Familial olivopontocerebellar atrophy with neonatal onset: A recessively inherited syndrome with systemic and biochemical abnormalities. J Neurol Neurosurg Psychiatry 1988; 51: 385-390.
8. Jaeken J, Hagberg B, Strømme P. Clinical presentation and natural course of the carbohydrate-deficient glycoprotein syndrome. Acta Paediatr Scand 1991; 375 (Suppl): 6-13.
9. Kristiansson B, Stibler H, Conradi N, Eriksson BO, Ryd W. The heart and pericardial effusions in CDGS-I (carbohydrate-deficient glycoprotein syndrome type I). J Inherit Metab Dis 1998; 21: 112-124.
10. Horslen SP, Clayton PT, Harding BN, Hall NA, Keir G, Winchester B. Olivopontocerebellar atrophy of neonatal onset and disialotransferrin developmental deficiency syndrome. Arch Dis Child 1991; 66: 1027-1032.
11. Hutchesson AC, Gray RG, Spencer DA, Keir G. Carbohydrate-deficient glycoprotein syndrome; multiple abnormalities and diagnostic delay. Arch Dis Child 1995; 72: 445-446.
12. Garcia Silva MT, de Castro J, Stibler H, et al. Prenatal hypertrophic cardiomyopathy and pericardial effusion in carbohydrate-deficient glycoprotein syndrome. J Inherit Metab Dis 1996; 19: 257-259.
13. Imtiaz F, Worthington V, Champion M, et al. Genotypes and phenotypes of patients in the UK with carbohydrate-deficient glycoprotein syndrome type 1. J Inherit Metab Dis 2000; 23: 162-174
14. Charlwood J, Clayton P, Johnson A, Keir G, Mian N, Winchester B (1997). A case of carbohydrate-deficient glycoprotein syndrome type 1 (CDGS type 1) with normal phosphomannomutase deficiency. J Inherit Metab Dis 2000; 20: 817-827.
15. Clayton P, Winchester B, di Tomaso E, Young E, Keir G, Rodeck C. Carbohydrate-deficient glycoprotein syndrome: Normal glycosylation in the fetus. Lancet 1993; 341: 956.
16. Di Rocco M, Barone R, Adami A, et al. Carbohydrate-deficient glycoprotein syndromes: The Italian experience. J Inherit Metab Dis 2000; 23: 391-395.
17. Freeze HH. Human glycosylation disorders and sugar supplement therapy. Biochem Biophys Res Comm 1999; 255: 189-193.
18. Niehues R, Hasilik M, Alton G, et al. Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy. J Clin Invest 1998; 101: 1414-1420.
19. Lühn K, Marquardt T, Harms E, Vestweber D. Discontinuation of fucose therapy in LAD II causes rapid loss of selectin ligands and rise of leukocyte counts. Blood 2001; 97: 330-332.
20. Marquardt T, Lühn K, Srikrishna G, Freeze HH, Harms E, Vestweber D. Correction of leukocyte adhesion deficiency type II with oral fucose. Blood 1999; 94: 3976-3985.
21. Schwartz ML, Cox GF, Lin AE, et al. Clinical approach to genetic cardiomyopathy in children. Circulation 1996; 94: 2021-2038.
22. Towbin JA. Pediatric myocardial disease. Pediatr Clin North Am 1999; 46: 289-312.
23. Badorff C, Lee GH, Lamphear BJ, et al. Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 1999; 5: 320-326.
24. Sakamoto A, Ono K, Abe M, et al. Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: An animal model of disrupted dystrophin-associated glycoprotein complex. Proc Natl Acad Sci USA 1997; 94: 13873-13878.
25. Mogensen J, Klausen IC, Pedersen AK, et al. Alpha-cardiac actin is a novel disease gene in familial hypertrohic cardiomyopathy. J Clin Invest 1999; 103: R39-R43.